nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Paclitaxel—ovarian cancer	0.0833	0.164	CbGbCtD
Oxybutynin—CYP2C8—Paclitaxel—ovarian cancer	0.0801	0.157	CbGbCtD
Oxybutynin—CYP2D6—Vinorelbine—ovarian cancer	0.0727	0.143	CbGbCtD
Oxybutynin—CYP3A4—Topotecan—ovarian cancer	0.0656	0.129	CbGbCtD
Oxybutynin—CYP3A5—Docetaxel—ovarian cancer	0.0602	0.118	CbGbCtD
Oxybutynin—CYP3A4—Vinorelbine—ovarian cancer	0.0462	0.0908	CbGbCtD
Oxybutynin—CYP3A4—Paclitaxel—ovarian cancer	0.0325	0.0638	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—ovarian cancer	0.0275	0.0541	CbGbCtD
Oxybutynin—CYP3A4—Docetaxel—ovarian cancer	0.0235	0.0461	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—ovarian cancer	0.0175	0.0344	CbGbCtD
Oxybutynin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000408	0.000831	CcSEcCtD
Oxybutynin—Anorexia—Paclitaxel—ovarian cancer	0.000404	0.000823	CcSEcCtD
Oxybutynin—Vomiting—Vinorelbine—ovarian cancer	0.0004	0.000816	CcSEcCtD
Oxybutynin—Dysuria—Epirubicin—ovarian cancer	0.000398	0.000812	CcSEcCtD
Oxybutynin—Rash—Vinorelbine—ovarian cancer	0.000397	0.000809	CcSEcCtD
Oxybutynin—Dermatitis—Vinorelbine—ovarian cancer	0.000397	0.000809	CcSEcCtD
Oxybutynin—Abdominal distension—Doxorubicin—ovarian cancer	0.000397	0.000808	CcSEcCtD
Oxybutynin—Hypotension—Paclitaxel—ovarian cancer	0.000396	0.000807	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000396	0.000807	CcSEcCtD
Oxybutynin—Headache—Vinorelbine—ovarian cancer	0.000395	0.000804	CcSEcCtD
Oxybutynin—Syncope—Docetaxel—ovarian cancer	0.000395	0.000804	CcSEcCtD
Oxybutynin—Dysphagia—Doxorubicin—ovarian cancer	0.000394	0.000803	CcSEcCtD
Oxybutynin—Asthma—Doxorubicin—ovarian cancer	0.000394	0.000803	CcSEcCtD
Oxybutynin—Influenza—Doxorubicin—ovarian cancer	0.000394	0.000803	CcSEcCtD
Oxybutynin—Pollakiuria—Epirubicin—ovarian cancer	0.000393	0.000802	CcSEcCtD
Oxybutynin—Palpitations—Docetaxel—ovarian cancer	0.000389	0.000792	CcSEcCtD
Oxybutynin—Loss of consciousness—Docetaxel—ovarian cancer	0.000387	0.000788	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000386	0.000787	CcSEcCtD
Oxybutynin—Cough—Docetaxel—ovarian cancer	0.000384	0.000782	CcSEcCtD
Oxybutynin—Insomnia—Paclitaxel—ovarian cancer	0.000383	0.000781	CcSEcCtD
Oxybutynin—Convulsion—Docetaxel—ovarian cancer	0.000381	0.000777	CcSEcCtD
Oxybutynin—Paraesthesia—Paclitaxel—ovarian cancer	0.00038	0.000775	CcSEcCtD
Oxybutynin—Hypertension—Docetaxel—ovarian cancer	0.00038	0.000774	CcSEcCtD
Oxybutynin—Infestation—Epirubicin—ovarian cancer	0.00038	0.000774	CcSEcCtD
Oxybutynin—Infestation NOS—Epirubicin—ovarian cancer	0.00038	0.000774	CcSEcCtD
Oxybutynin—Drowsiness—Epirubicin—ovarian cancer	0.00038	0.000774	CcSEcCtD
Oxybutynin—Bronchitis—Doxorubicin—ovarian cancer	0.000379	0.000772	CcSEcCtD
Oxybutynin—Somnolence—Paclitaxel—ovarian cancer	0.000377	0.000767	CcSEcCtD
Oxybutynin—Chest pain—Docetaxel—ovarian cancer	0.000375	0.000763	CcSEcCtD
Oxybutynin—Arthralgia—Docetaxel—ovarian cancer	0.000375	0.000763	CcSEcCtD
Oxybutynin—Nausea—Vinorelbine—ovarian cancer	0.000374	0.000762	CcSEcCtD
Oxybutynin—Dyspepsia—Paclitaxel—ovarian cancer	0.000373	0.00076	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000372	0.000758	CcSEcCtD
Oxybutynin—Stomatitis—Epirubicin—ovarian cancer	0.00037	0.000754	CcSEcCtD
Oxybutynin—Urinary tract infection—Epirubicin—ovarian cancer	0.000369	0.000752	CcSEcCtD
Oxybutynin—Conjunctivitis—Epirubicin—ovarian cancer	0.000369	0.000752	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—ovarian cancer	0.000369	0.000751	CcSEcCtD
Oxybutynin—Decreased appetite—Paclitaxel—ovarian cancer	0.000368	0.00075	CcSEcCtD
Oxybutynin—Dry mouth—Docetaxel—ovarian cancer	0.000366	0.000747	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000366	0.000746	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000366	0.000745	CcSEcCtD
Oxybutynin—Fatigue—Paclitaxel—ovarian cancer	0.000365	0.000744	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—ovarian cancer	0.000364	0.000742	CcSEcCtD
Oxybutynin—Pain—Paclitaxel—ovarian cancer	0.000362	0.000738	CcSEcCtD
Oxybutynin—Constipation—Paclitaxel—ovarian cancer	0.000362	0.000738	CcSEcCtD
Oxybutynin—Haematuria—Epirubicin—ovarian cancer	0.000362	0.000738	CcSEcCtD
Oxybutynin—Confusional state—Docetaxel—ovarian cancer	0.000362	0.000738	CcSEcCtD
Oxybutynin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000359	0.000732	CcSEcCtD
Oxybutynin—Oedema—Docetaxel—ovarian cancer	0.000359	0.000732	CcSEcCtD
Oxybutynin—Epistaxis—Epirubicin—ovarian cancer	0.000358	0.00073	CcSEcCtD
Oxybutynin—Infection—Docetaxel—ovarian cancer	0.000357	0.000727	CcSEcCtD
Oxybutynin—Sinusitis—Epirubicin—ovarian cancer	0.000356	0.000726	CcSEcCtD
Oxybutynin—Shock—Docetaxel—ovarian cancer	0.000353	0.00072	CcSEcCtD
Oxybutynin—Nervous system disorder—Docetaxel—ovarian cancer	0.000352	0.000718	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—ovarian cancer	0.000351	0.000716	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—ovarian cancer	0.000351	0.000716	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—ovarian cancer	0.000351	0.000716	CcSEcCtD
Oxybutynin—Tachycardia—Docetaxel—ovarian cancer	0.00035	0.000714	CcSEcCtD
Oxybutynin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000349	0.000711	CcSEcCtD
Oxybutynin—Skin disorder—Docetaxel—ovarian cancer	0.000349	0.000711	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000346	0.000706	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—ovarian cancer	0.000343	0.000698	CcSEcCtD
Oxybutynin—Anorexia—Docetaxel—ovarian cancer	0.000342	0.000697	CcSEcCtD
Oxybutynin—Rhinitis—Epirubicin—ovarian cancer	0.000342	0.000696	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000342	0.000696	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—ovarian cancer	0.000342	0.000696	CcSEcCtD
Oxybutynin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000339	0.000691	CcSEcCtD
Oxybutynin—Pharyngitis—Epirubicin—ovarian cancer	0.000338	0.000689	CcSEcCtD
Oxybutynin—Urinary tract disorder—Epirubicin—ovarian cancer	0.000337	0.000686	CcSEcCtD
Oxybutynin—Urticaria—Paclitaxel—ovarian cancer	0.000337	0.000686	CcSEcCtD
Oxybutynin—Oedema peripheral—Epirubicin—ovarian cancer	0.000336	0.000684	CcSEcCtD
Oxybutynin—Hypotension—Docetaxel—ovarian cancer	0.000336	0.000684	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—ovarian cancer	0.000335	0.000683	CcSEcCtD
Oxybutynin—Connective tissue disorder—Epirubicin—ovarian cancer	0.000335	0.000683	CcSEcCtD
Oxybutynin—Abdominal pain—Paclitaxel—ovarian cancer	0.000335	0.000682	CcSEcCtD
Oxybutynin—Urethral disorder—Epirubicin—ovarian cancer	0.000334	0.000681	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—ovarian cancer	0.000331	0.000675	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—ovarian cancer	0.00033	0.000672	CcSEcCtD
Oxybutynin—Visual impairment—Epirubicin—ovarian cancer	0.000329	0.000669	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000327	0.000667	CcSEcCtD
Oxybutynin—Insomnia—Docetaxel—ovarian cancer	0.000325	0.000662	CcSEcCtD
Oxybutynin—Paraesthesia—Docetaxel—ovarian cancer	0.000322	0.000657	CcSEcCtD
Oxybutynin—Somnolence—Docetaxel—ovarian cancer	0.000319	0.000651	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—ovarian cancer	0.000319	0.000649	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—ovarian cancer	0.000318	0.000648	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—ovarian cancer	0.000316	0.000645	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—ovarian cancer	0.000316	0.000645	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—ovarian cancer	0.000316	0.000644	CcSEcCtD
Oxybutynin—Dyspepsia—Docetaxel—ovarian cancer	0.000316	0.000644	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000314	0.00064	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—ovarian cancer	0.000313	0.000638	CcSEcCtD
Oxybutynin—Decreased appetite—Docetaxel—ovarian cancer	0.000312	0.000636	CcSEcCtD
Oxybutynin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000312	0.000636	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000312	0.000635	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000311	0.000633	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00031	0.000632	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00031	0.000632	CcSEcCtD
Oxybutynin—Fatigue—Docetaxel—ovarian cancer	0.00031	0.000631	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—ovarian cancer	0.000309	0.00063	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—ovarian cancer	0.000309	0.00063	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—ovarian cancer	0.000307	0.000626	CcSEcCtD
Oxybutynin—Constipation—Docetaxel—ovarian cancer	0.000307	0.000626	CcSEcCtD
Oxybutynin—Pain—Docetaxel—ovarian cancer	0.000307	0.000626	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—ovarian cancer	0.000305	0.000621	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—ovarian cancer	0.000304	0.000619	CcSEcCtD
Oxybutynin—Asthenia—Paclitaxel—ovarian cancer	0.000304	0.000619	CcSEcCtD
Oxybutynin—Pruritus—Paclitaxel—ovarian cancer	0.0003	0.000611	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—ovarian cancer	0.000299	0.000609	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—ovarian cancer	0.000297	0.000605	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—ovarian cancer	0.000297	0.000605	CcSEcCtD
Oxybutynin—Feeling abnormal—Docetaxel—ovarian cancer	0.000296	0.000603	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—ovarian cancer	0.000295	0.000601	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—ovarian cancer	0.000294	0.000599	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000294	0.000598	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—ovarian cancer	0.000293	0.000597	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—ovarian cancer	0.000293	0.000597	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—ovarian cancer	0.000292	0.000596	CcSEcCtD
Oxybutynin—Tension—Epirubicin—ovarian cancer	0.000291	0.000593	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—ovarian cancer	0.000291	0.000592	CcSEcCtD
Oxybutynin—Diarrhoea—Paclitaxel—ovarian cancer	0.00029	0.000591	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—ovarian cancer	0.000288	0.000587	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—ovarian cancer	0.000287	0.000585	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—ovarian cancer	0.000286	0.000583	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000284	0.000579	CcSEcCtD
Oxybutynin—Abdominal pain—Docetaxel—ovarian cancer	0.000284	0.000578	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—ovarian cancer	0.000282	0.000574	CcSEcCtD
Oxybutynin—Dizziness—Paclitaxel—ovarian cancer	0.00028	0.000571	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—ovarian cancer	0.00028	0.00057	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—ovarian cancer	0.000276	0.000563	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000275	0.000561	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—ovarian cancer	0.000275	0.00056	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—ovarian cancer	0.000275	0.00056	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—ovarian cancer	0.000273	0.000556	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—ovarian cancer	0.000271	0.000551	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—ovarian cancer	0.000269	0.000549	CcSEcCtD
Oxybutynin—Vomiting—Paclitaxel—ovarian cancer	0.000269	0.000549	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—ovarian cancer	0.000269	0.000548	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—ovarian cancer	0.000268	0.000545	CcSEcCtD
Oxybutynin—Rash—Paclitaxel—ovarian cancer	0.000267	0.000544	CcSEcCtD
Oxybutynin—Dermatitis—Paclitaxel—ovarian cancer	0.000267	0.000544	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—ovarian cancer	0.000267	0.000543	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—ovarian cancer	0.000266	0.000542	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—ovarian cancer	0.000266	0.000541	CcSEcCtD
Oxybutynin—Headache—Paclitaxel—ovarian cancer	0.000265	0.000541	CcSEcCtD
Oxybutynin—Hypersensitivity—Docetaxel—ovarian cancer	0.000265	0.000539	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—ovarian cancer	0.000262	0.000534	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—ovarian cancer	0.000261	0.000532	CcSEcCtD
Oxybutynin—Cough—Epirubicin—ovarian cancer	0.000259	0.000528	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—ovarian cancer	0.000259	0.000527	CcSEcCtD
Oxybutynin—Asthenia—Docetaxel—ovarian cancer	0.000258	0.000525	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—ovarian cancer	0.000257	0.000524	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—ovarian cancer	0.000256	0.000522	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000255	0.000519	CcSEcCtD
Oxybutynin—Pruritus—Docetaxel—ovarian cancer	0.000254	0.000518	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—ovarian cancer	0.000253	0.000515	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—ovarian cancer	0.000253	0.000515	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—ovarian cancer	0.000252	0.000514	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—ovarian cancer	0.000252	0.000513	CcSEcCtD
Oxybutynin—Nausea—Paclitaxel—ovarian cancer	0.000252	0.000513	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000251	0.000511	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—ovarian cancer	0.00025	0.000509	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—ovarian cancer	0.000248	0.000505	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—ovarian cancer	0.000247	0.000504	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—ovarian cancer	0.000246	0.000502	CcSEcCtD
Oxybutynin—Diarrhoea—Docetaxel—ovarian cancer	0.000246	0.000501	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—ovarian cancer	0.000244	0.000498	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—ovarian cancer	0.000243	0.000494	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000242	0.000494	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—ovarian cancer	0.000242	0.000494	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000241	0.000492	CcSEcCtD
Oxybutynin—Infection—Epirubicin—ovarian cancer	0.000241	0.00049	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—ovarian cancer	0.00024	0.000488	CcSEcCtD
Oxybutynin—Shock—Epirubicin—ovarian cancer	0.000238	0.000486	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—ovarian cancer	0.000238	0.000485	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—ovarian cancer	0.000238	0.000484	CcSEcCtD
Oxybutynin—Dizziness—Docetaxel—ovarian cancer	0.000237	0.000484	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—ovarian cancer	0.000237	0.000483	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—ovarian cancer	0.000236	0.000482	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—ovarian cancer	0.000235	0.000479	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—ovarian cancer	0.000234	0.000476	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—ovarian cancer	0.000234	0.000476	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—ovarian cancer	0.000233	0.000475	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000232	0.000473	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—ovarian cancer	0.000231	0.000471	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—ovarian cancer	0.000231	0.00047	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—ovarian cancer	0.000229	0.000466	CcSEcCtD
Oxybutynin—Vomiting—Docetaxel—ovarian cancer	0.000228	0.000465	CcSEcCtD
Oxybutynin—Rash—Docetaxel—ovarian cancer	0.000226	0.000461	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—ovarian cancer	0.000226	0.000461	CcSEcCtD
Oxybutynin—Dermatitis—Docetaxel—ovarian cancer	0.000226	0.000461	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—ovarian cancer	0.000226	0.00046	CcSEcCtD
Oxybutynin—Headache—Docetaxel—ovarian cancer	0.000225	0.000458	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000224	0.000457	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—ovarian cancer	0.000224	0.000457	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—ovarian cancer	0.000223	0.000454	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000221	0.00045	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—ovarian cancer	0.00022	0.000449	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—ovarian cancer	0.00022	0.000448	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—ovarian cancer	0.000219	0.000446	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—ovarian cancer	0.000219	0.000446	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—ovarian cancer	0.000218	0.000444	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—ovarian cancer	0.000217	0.000443	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—ovarian cancer	0.000215	0.000439	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—ovarian cancer	0.000214	0.000435	CcSEcCtD
Oxybutynin—Nausea—Docetaxel—ovarian cancer	0.000213	0.000435	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—ovarian cancer	0.000213	0.000434	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—ovarian cancer	0.000211	0.000429	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—ovarian cancer	0.000209	0.000427	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000209	0.000426	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—ovarian cancer	0.000209	0.000426	CcSEcCtD
Oxybutynin—Pain—Epirubicin—ovarian cancer	0.000207	0.000422	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—ovarian cancer	0.000207	0.000422	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000204	0.000416	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—ovarian cancer	0.000203	0.000413	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—ovarian cancer	0.000201	0.00041	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—ovarian cancer	0.0002	0.000407	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—ovarian cancer	0.000199	0.000406	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000198	0.000404	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—ovarian cancer	0.000197	0.000402	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—ovarian cancer	0.000195	0.000397	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000193	0.000394	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—ovarian cancer	0.000193	0.000394	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—ovarian cancer	0.000192	0.000392	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—ovarian cancer	0.000192	0.000391	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—ovarian cancer	0.000192	0.000391	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—ovarian cancer	0.000191	0.00039	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000185	0.000376	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000183	0.000373	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—ovarian cancer	0.000178	0.000364	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—ovarian cancer	0.000178	0.000363	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—ovarian cancer	0.000177	0.000361	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—ovarian cancer	0.000174	0.000354	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—ovarian cancer	0.000171	0.000349	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—ovarian cancer	0.000166	0.000338	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—ovarian cancer	0.000165	0.000336	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—ovarian cancer	0.000161	0.000328	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—ovarian cancer	0.00016	0.000326	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—ovarian cancer	0.000159	0.000323	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—ovarian cancer	0.000154	0.000314	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—ovarian cancer	0.000153	0.000312	CcSEcCtD
Oxybutynin—Rash—Epirubicin—ovarian cancer	0.000153	0.000311	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—ovarian cancer	0.000153	0.000311	CcSEcCtD
Oxybutynin—Headache—Epirubicin—ovarian cancer	0.000152	0.000309	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—ovarian cancer	0.000148	0.000302	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—ovarian cancer	0.000144	0.000293	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—ovarian cancer	0.000142	0.00029	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—ovarian cancer	0.000141	0.000288	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—ovarian cancer	0.000141	0.000288	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—ovarian cancer	0.00014	0.000286	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—ovarian cancer	0.000133	0.000271	CcSEcCtD
